Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2

A pipeline of effective direct-acting antivirals (DAAs) remains a critical gap in addressing the current pandemic given vaccination hesitancy, the emergence of viral variants of concern, susceptible populations for which vaccination is ineffective or unavailable, and the possibility that coronavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonsson, Colleen B, Golden, Jennifer E, Meibohm, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238655/
https://www.ncbi.nlm.nih.gov/pubmed/34256351
http://dx.doi.org/10.1016/j.coviro.2021.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238655/
https://www.ncbi.nlm.nih.gov/pubmed/34256351
http://dx.doi.org/10.1016/j.coviro.2021.06.008

Ejemplares similares